pharmacogenomics
study of genomic influence on drug response
pharmacogenetics
study of individual gene-drug rxns
-usually 1 or 2 genes having dominant effect on drug response
mutation
altering DNA sequence - rare in population
polymorphism
altering DNA sequence - common in population
-affect >1%
single nucleotide polymorphism
most common - marker for pinpointing disease or mapping therapeutic outcome
indels
short repeats in the promote that add or subtract amino acids
-insertions/deletions
copy number variation (CNVs)
genomic DNA involved in duplication, deletion, or inversion
haplotype
combination of alleles or SNPs that tend to be inherited together - linkage disequilibrium
-determines the phenotype
Beta2 adrenergic receptor polymorphisms
depending on haplotype of the patient, may not respond to albuterol to help relieve asthma
-may need to take more drug to have effect
pharmacodynamics - simple mutation in drug receptor
can totally change the affect of the drug - change in drug target
-agonist –> partial agonist or vice versa for ex.
pharmacokinetics polymorphisms
change in metabolizer enzyme function determines whether you get the therapeutic effect or side effects of the drug
cytochrome P450 enzymes
NAT2
phase 2 enzyme who metabolizing effects may lead to a higher susceptibility to cancer
-found in liver - activates and deactivates many chemicals such as cigarettes